Definitive Contract HHSN268201400005C

This federal contract award, with an ID of HHSN268201400005C, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the Regents of the University of California, San Francisco (UCSF). The contract is for the "VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES" program, with a base period from November 15, 2013 to November 14, 2014 and a total completion date of November 14, 2016. The contract, which is a definitive contract with cost no fee pricing, has a ceiling value of $947,642.98. UCSF is a leading academic medical center and research institution that partners extensively with federal agencies on biomedical research and healthcare initiatives. This contract supports research and development related to vascular interventions and therapeutic advances, with a focus on pro-resolving vascular devices. The contract was awarded without a set-aside.